Cardiovascular Diseases Research in Rhode Island

The 93.837–Rhode Island intersection

The cell sums award obligations with CFDA 93.837 and a RI place-of-performance tag. $159,771,343.94 is that sum. It is not a ranking of Rhode Island against other states. Campaign-finance tables are a different dataset; FEC donations do not fund these USAspending obligations.

One hundred eight awards is a multi-project extramural file: research assistance often posts as about a hundred discrete records rather than one statewide block. The join does not name recipients. Packet facts are $159,771,343.94, 108 awards, RI, and 93.837. Correlation is not causation. FEC donations do not fund this USAspending cell. Keep Cardiovascular diseases research and Rhode Island together when reading $159,771,343.94.

Heart-disease research as a listing, not a clinic file

CFDA 93.837 is CARDIOVASCULAR DISEASES RESEARCH. Packet facts on the program side stop at the name Cardiovascular Diseases Research, the number 93.837, $159,771,343.94, and 108 awards. This packet lists no award recipients and no contractor names. Mixing this listing with other health-research catalog lines that use different CFDA numbers would invent a combined total the packet never computed. CARDIOVASCULAR DISEASES RESEARCH is the catalog title. One hundred eight awards is a multi-project extramural file: research assistance often posts as about a hundred discrete records rather than one statewide block. The join does not convert dollars into labs, investigators, or patients. Neighbor-state Cardiovascular diseases research joins are other pairs.

Cardiovascular Diseases Research is not an allergy-research twin and not an addiction-research twin. Those are other CFDA numbers. One hundred eight records against $159,771,343.94 do not name principal investigators. A 93.837 award tagged to Massachusetts stays outside this Rhode Island cell even if a lab collaboration crosses the border.

Questions

How much Cardiovascular diseases research funding is obligated in Rhode Island?

USAspending.gov records $159,771,343.94 in CFDA 93.837 obligations with Rhode Island place of performance on 108 awards. That is the pair total, not an outlay and not a patient census, a lab inventory, or a named-investigator roster. Keep Cardiovascular Diseases Research and Rhode Island together when citing $159,771,343.94.

Do 108 awards mean 108 Rhode Island laboratories?

No. 108 is a USAspending award-record count, not 108 labs, investigators, or patients. The implied mean is about $1,479,364.30 per award. Unique recipients are unpublished. Obligations of $159,771,343.94 are not outlays. USAspending.gov remains the source for this 93.837 × RI pair.

Is this Rhode Island’s full federal health-research spend?

No. $159,771,343.94 is only the CFDA 93.837 × Rhode Island cell. Other catalogs appear on separate Rhode Island program pages. Nationwide 93.837 is not limited to Rhode Island. Mixing this listing with other health-research catalog lines that use different CFDA numbers would invent a larger total.

Where is the live 93.837 × Rhode Island table?

Cardiovascular Diseases Research in Rhode Island is the overlay at /states/ri/programs/93.837/. CFDA 93.837 is /programs/93.837/. Rhode Island federal spending is /states/ri/. Rhode Island programs is /states/ri/programs/. All spending ties is /ties/. Original filings remain on USAspending.gov for this 93.837 × RI pair.